Elon Musk’s Neuralink has developed a chip capable of reading human thoughts, aiming for revolutionary brain-computer communication.
Meanwhile, China has entered the race with its own commercial BCI system named NEO.
The NEO chip, developed by Neuracle Technology in partnership with Tsinghua University, received approval from China’s National Medical Products Administration in March.
NEO’s Design and Functionality
NEO targets patients aged 18-60 who experience paralysis, aiming to restore limited mobility efficiently.
Unlike Neuralink, NEO does not require deep brain implantation.
The system uses eight sensors placed on the protective dura mater layer.
These sensors collect brain signals and transmit them to a computer, which then converts commands for robotic gloves.
Users can manipulate objects and perform daily activities with minimal risk of tissue damage or bleeding.
Real-World Testing Shows Promise
The chip underwent trials with 39-year-old Dong Hui, who became paralyzed from the neck down six years prior.
After surgery in 2024 and a year of rehabilitation, NEO enabled Hui to hold a pen and write using thought commands.
Integrating AI with BCI
Chinese companies are now combining NEO with artificial intelligence to expand functionality.
NeuroXess in Shanghai successfully enabled a paralyzed patient to move a computer cursor using thought alone.
The patient also operated home appliances and communicated through a large language model interpreting Mandarin speech at 300 characters per minute.
This advancement offers hope for individuals unable to speak or perform basic movements independently.
Strategic Implications
China’s commercial approval of NEO positions it as a major competitor to Neuralink in the brain-computer interface sector.
The technology could redefine patient care and accessibility for the disabled, enhancing independence worldwide.
